Blockade Medical pulled in $2.2 million and is looking for another $5.8 million in a new round of equity financing, according to an SEC filing published today.
Irvine, Calif.-based Blockade Medical is developing catheter based therapeutic devices for treating cerebral aneurysms.
The company’s flagship device is the Barricade embolization coil system designed to occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels, according to the company’s site.
The device is a bare platinum coil line available in framing, filling and finishing shapes, and has both CE Mark approval in the European Union and U.S. FDA 510(k) clearance.
The company did not comment on any intended uses for the funds, which came from 6 anonymous investors, according to the SEC filing.
The post Embolization coil maker Blockade Medical pulls in $2.2m appeared first on MassDevice.
from MassDevice http://ift.tt/1GtoeLO
Cap comentari:
Publica un comentari a l'entrada